Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Abstract

.2% of Candida isolates tested were susceptible (S) to fluconazole; however, 13 of 31 species identified exhibited decreased susceptibility (<75% S), similar to that seen with the resistant (R) species C. glabrata and C. krusei. Among 197,619 isolates of Candida spp. tested against voriconazole, 95.0% were S and 3% were R. About 30% of fluconazole-R isolates of C. albicans, C. glabrata, C. tropicalis, C. rugosa, C. lipolytica, C. pelliculosa, C. apicola, C. haemulonii, C. humicola, C. lambica, and C. ciferrii remained S to voriconazole. An increase in fluconazole resistance over time was seen with C. parapsilosis, C. guilliermondii, C. lusitaniae, C. sake, and C. pelliculosa. Among the emerging fluconazole-R species were C. guilliermondii (11.4% R), C. inconspicua (53.2% R), C. rugosa (41.8% R), and C. norvegensis (40.7% R). The rates of isolation of C. rugosa, C. inconspicua, and C. norvegensis increased by 5-to 10-fold over the 10.5-year study period. C. guilliermondii and C. rugosa were most prominent in Latin America, whereas C. inconspicua and C. norvegensis were most common in Eastern European countries. This survey identifies several less-common species of Candida with decreased susceptibility to azoles. These organisms may pose a future threat to optimal antifungal therapy and underscore the importance of prompt and accurate species identification and antifungal susceptibility testing.Antifungal susceptibility testing is playing an increasing role as a means to track the development of antifungal resistance in epidemiological studies (2, 10, 12, 17, 27, 45-47, 55, 63). One of the important by-products of the standardization of antifungal susceptibility testing has been the ability to conduct surveillance for antifungal resistance using uniform methods (44). Meaningful large-scale surveys of antifungal susceptibility and resistance conducted over time would not be possible without a standardized broth microdilution (BMD) or disk diffusion (DD) method for performing the in vitro studies (12,38,60). Global surveillance programs such as the ARTEMIS antifungal surveillance program for DD testing (49,57,60) and MIC testing (12, 13), the European Confederation of Medical Mycology (ECMM) survey of candidemia (68), and the SENTRY Antifungal Surveillance Program (36-38) promote the use of standardized DD and BMD methods and provide useful and consistent antifungal susceptibility data from a broad international network of hospitals and laboratories.The ARTEMIS global antifungal surveillance program is among the most comprehensive and long-running fungal surveillance programs (12,45,57,58,60). The ARTEMIS program was designed to address many of the potential limitations of resistance surveillance studies (26): (i) it is both longitudinal (1997 to present) and global (142 participating sites in 41 countries) in scope, (ii) it employs standardized DD (7) and BMD (9) antifungal susceptibility test methods, (iii) both internal quality control (QC) performed in each participating laboratory and external quality assurance...

Glutathione biosynthesis in the yeast pathogens Candida glabrata and Candida albicans: essential in C. glabrata, and essential for virulence in C. albicans

“…These findings describing the essentiality of glutathione biosynthesis in these pathogens prompted us to investigate the importance, if any, of glutathione biosynthesis in the survival of yeast pathogens in their mammalian host. Candida albicans and Candida glabrata are the two most important yeast pathogens that cause bloodstream infections (Fidel et al, 1999;Pfaller et al, 2010;Wingard, 1995). Although C. glabrata is phylogenetically much closer to Saccharomyces cerevisiae than to C. albicans, both are human commensals and are rarely seen in the environment outside the human host, where their ecological niche is the vaginal mucosa, skin and blood (Fidel et al, 1999;Kaur et al, 2005).…”

The Rho1 GTPase-activating Protein CgBem2 Is Required for Survival of Azole Stress in Candida glabrata

“…Candida species are the leading cause of disseminated fungal infections and rank fourth among the most common nosocomial blood culture isolates in intensive care units (1,2). Although Candida albicans still accounts for about 60% of total blood stream infections, systemic infections due to non-albicans species of Candida such as Candida glabrata, krusei, tropicalis, and parapsilosis have increased significantly in the last two decades (2,3). C. glabrata is the second or third most common yeast pathogen found in blood stream infections depending upon the geographical location (3).…”

Cyanobacteria, Lyngbya aestuarii and Aphanothece bullosa as antifungal and antileishmanial drug resources

“…Among other diseases of concern to scientists, leishmaniasis is caused by species of related genus of Leishmania [32][33][34] . There are limitations with regards to antifungal and antileishmanial drugs because of their price and side effects [35] .…”